Utah Medical Products PE Ratio 2011-2025 | UTMD
Current and historical p/e ratio for Utah Medical Products (UTMD) from 2011 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Utah Medical Products PE ratio as of November 12, 2025 is 16.16.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Utah Medical Products PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-11-12 | 56.20 | 15.03 | |
| 2025-06-30 | 56.64 | $3.74 | 15.14 |
| 2025-03-31 | 55.46 | $3.78 | 14.67 |
| 2024-12-31 | 60.51 | $3.95 | 15.32 |
| 2024-09-30 | 65.54 | $4.27 | 15.35 |
| 2024-06-30 | 65.16 | $4.33 | 15.05 |
| 2024-03-31 | 69.04 | $4.50 | 15.34 |
| 2023-12-31 | 81.42 | $4.57 | 17.82 |
| 2023-09-30 | 82.85 | $4.64 | 17.86 |
| 2023-06-30 | 89.47 | $4.74 | 18.88 |
| 2023-03-31 | 90.70 | $4.71 | 19.26 |
| 2022-12-31 | 95.90 | $4.51 | 21.26 |
| 2022-09-30 | 81.13 | $4.39 | 18.48 |
| 2022-06-30 | 81.42 | $4.36 | 18.67 |
| 2022-03-31 | 84.88 | $4.18 | 20.31 |
| 2021-12-31 | 94.15 | $4.05 | 23.25 |
| 2021-09-30 | 85.83 | $3.85 | 22.29 |
| 2021-06-30 | 78.37 | $3.50 | 22.39 |
| 2021-03-31 | 79.54 | $2.92 | 27.24 |
| 2020-12-31 | 77.19 | $2.93 | 26.34 |
| 2020-09-30 | 72.90 | $3.17 | 23.00 |
| 2020-06-30 | 80.60 | $3.36 | 23.99 |
| 2020-03-31 | 85.29 | $3.94 | 21.65 |
| 2019-12-31 | 97.54 | $3.94 | 24.76 |
| 2019-09-30 | 86.41 | $3.68 | 23.48 |
| 2019-06-30 | 86.04 | $4.49 | 19.16 |
| 2019-03-31 | 79.07 | $4.70 | 16.82 |
| 2018-12-31 | 74.20 | $4.95 | 14.99 |
| 2018-09-30 | 83.87 | $3.37 | 24.89 |
| 2018-06-30 | 97.79 | $2.54 | 38.50 |
| 2018-03-31 | 87.53 | $2.43 | 36.02 |
| 2017-12-31 | 71.87 | $2.29 | 31.38 |
| 2017-09-30 | 64.72 | $3.68 | 17.59 |
| 2017-06-30 | 63.48 | $3.49 | 18.19 |
| 2017-03-31 | 54.42 | $3.31 | 16.44 |
| 2016-12-31 | 63.27 | $3.21 | 19.71 |
| 2016-09-30 | 51.81 | $3.34 | 15.51 |
| 2016-06-30 | 54.35 | $3.37 | 16.13 |
| 2016-03-31 | 53.74 | $3.28 | 16.38 |
| 2015-12-31 | 50.09 | $3.14 | 15.95 |
| 2015-09-30 | 45.88 | $3.09 | 14.85 |
| 2015-06-30 | 50.54 | $3.03 | 16.68 |
| 2015-03-31 | 50.50 | $3.01 | 16.78 |
| 2014-12-31 | 50.45 | $3.02 | 16.70 |
| 2014-09-30 | 40.78 | $3.14 | 12.99 |
| 2014-06-30 | 42.81 | $3.07 | 13.94 |
| 2014-03-31 | 47.90 | $3.02 | 15.86 |
| 2013-12-31 | 47.13 | $3.03 | 15.55 |
| 2013-09-30 | 48.76 | $2.72 | 17.92 |
| 2013-06-30 | 44.32 | $2.77 | 16.00 |
| 2013-03-31 | 39.60 | $2.72 | 14.56 |
| 2012-12-31 | 29.13 | $2.75 | 10.59 |
| 2012-09-30 | 27.27 | $2.65 | 10.29 |
| 2012-06-30 | 26.71 | $2.53 | 10.56 |
| 2012-03-31 | 24.60 | $2.42 | 10.16 |
| 2011-12-31 | 21.19 | $2.03 | 10.44 |
| 2011-09-30 | 20.60 | $1.93 | 10.67 |
| 2011-06-30 | 20.24 | $1.74 | 11.63 |
| 2011-03-31 | 22.08 | $1.60 | 13.80 |
| 2010-12-31 | 20.35 | $1.65 | 12.34 |
| 2010-09-30 | 21.41 | $1.66 | 12.90 |
| 2010-06-30 | 18.09 | $1.68 | 10.77 |
| 2010-03-31 | 20.24 | $1.70 | 11.91 |
| 2009-12-31 | 20.93 | $1.72 | 12.17 |
| 2009-09-30 | 20.76 | $1.72 | 12.07 |
| 2009-06-30 | 18.76 | $1.75 | 10.72 |
| 2009-03-31 | 16.00 | $1.82 | 8.79 |
| 2008-12-31 | 15.12 | $1.86 | 8.13 |
| 2008-09-30 | 18.79 | $1.93 | 9.73 |
| 2008-06-30 | 19.26 | $1.97 | 9.78 |
| 2008-03-31 | 19.87 | $1.98 | 10.03 |
| 2007-12-31 | 19.79 | $1.98 | 10.00 |
| 2007-09-30 | 20.75 | $2.00 | 10.37 |
| 2007-06-30 | 20.84 | $1.99 | 10.47 |
| 2007-03-31 | 22.21 | $2.00 | 11.10 |
| 2006-12-31 | 21.35 | $2.02 | 10.57 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.183B | $0.041B |
| Utah Medical Products is in the business of producing cost-effective devices for the healthcare industry which are predominantly proprietary, disposable and for hospital use. The company's success in rapidly producing solutions comes from its proven ability to integrate a number of engineering and technical disciplines in electronics, software, mechanical packaging, instrumentation, optics and materials. The resulting proprietary products represent significant incremental improvementsover existing clinical techniques. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $220.837B | 25.45 |
| EssilorLuxottica (ESLOY) | France | $169.692B | 0.00 |
| Boston Scientific (BSX) | United States | $151.950B | 34.75 |
| Stryker (SYK) | United States | $139.087B | 27.62 |
| Medtronic (MDT) | Ireland | $122.368B | 17.25 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.739B | 0.00 |
| Agilent Technologies (A) | United States | $42.361B | 27.42 |
| ResMed (RMD) | United States | $36.840B | 25.50 |
| GE HealthCare Technologies (GEHC) | United States | $33.440B | 15.99 |
| Koninklijke Philips (PHG) | Netherlands | $28.242B | 18.45 |
| Terumo (TRUMY) | Japan | $24.252B | 28.74 |
| Insulet (PODD) | United States | $22.953B | 71.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.539B | 10.94 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.204B | 0.00 |
| Baxter (BAX) | United States | $9.382B | 7.57 |
| Sunny Optical Technology (SNPTF) | China | $9.339B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.452B | 30.39 |
| Demant (WILYY) | Denmark | $7.496B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.539B | 10.78 |
| ICU Medical (ICUI) | United States | $3.536B | 22.45 |
| Haemonetics (HAE) | United States | $3.358B | 14.94 |
| Envista Holdings (NVST) | United States | $3.323B | 19.07 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.913B | 13.28 |
| LeMaitre Vascular (LMAT) | United States | $2.050B | 41.26 |
| Perrigo (PRGO) | Ireland | $1.968B | 4.93 |
| Curaleaf Holdings (CURLF) | Canada | $1.896B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.837B | 18.35 |
| AtriCure (ATRC) | United States | $1.634B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.504B | 65.91 |
| QuidelOrtho (QDEL) | United States | $1.487B | 9.56 |
| Tilray Brands (TLRY) | Canada | $1.448B | 0.00 |
| Neogen (NEOG) | United States | $1.419B | 27.21 |
| Kestra Medical Technologies (KMTS) | United States | $1.418B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.291B | 18.71 |
| BioLife Solutions (BLFS) | United States | $1.254B | 372.00 |
| InMode (INMD) | Israel | $0.917B | 10.36 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.830B | 0.00 |
| Valneva SE (VALN) | France | $0.764B | 0.00 |
| Surmodics (SRDX) | United States | $0.585B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.517B | 17.80 |
| SNDL (SNDL) | Canada | $0.486B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.481B | 0.00 |
| Omeros (OMER) | United States | $0.469B | 0.00 |
| CeriBell (CBLL) | United States | $0.464B | 0.00 |
| Evolus (EOLS) | United States | $0.453B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.431B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.303B | 0.00 |
| Brainsway (BWAY) | Israel | $0.288B | 50.60 |
| Canopy Growth (CGC) | Canada | $0.288B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.283B | 0.00 |
| High Tide (HITI) | Canada | $0.261B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.256B | 151.67 |
| Sanara MedTech (SMTI) | United States | $0.250B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.241B | 19.24 |
| Quanterix (QTRX) | United States | $0.234B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.224B | 0.00 |
| Organigram Global (OGI) | Canada | $0.221B | 0.00 |
| Owens & Minor (OMI) | United States | $0.220B | 2.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.216B | 0.00 |
| Exagen (XGN) | United States | $0.209B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.195B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.180B | 22.17 |
| OraSure Technologies (OSUR) | United States | $0.176B | 0.00 |
| Apyx Medical (APYX) | United States | $0.153B | 0.00 |
| Biote (BTMD) | United States | $0.129B | 5.21 |
| Jushi Holdings (JUSHF) | United States | $0.128B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.103B | 0.00 |
| Sharps Technology (STSS) | United States | $0.103B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.099B | 0.00 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.33 |
| Agape ATP (ATPC) | $0.065B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.057B | 33.00 |
| Nephros (NEPH) | United States | $0.046B | 33.31 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Jin Medical (ZJYL) | China | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Zynex (ZYXI) | United States | $0.035B | 0.00 |
| Bonk (BNKK) | United States | $0.033B | 0.00 |
| United-Guardian (UG) | United States | $0.029B | 14.77 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |